Amylin Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing innovative medicines to improve the lives of people with metabolic deseases.
Patient Resources | Email Sign-up | Contact Us
Home About Us Pipeline Research Investors Careers  
Challenging Science. Changing Lives.
Patient Stories
Investor Relations
News, SEC filings, presentation archives, stock information
Research Capabilities
Career Opportunities
Strategic Alliances
Development Pipeline
THERAPEUTIC FOCUS Diabetes Obesity

Amylin is dedicated to improving lives through the discovery, development and commercialization of innovative medicines for the treatment of diabetes and obesity.

Company Information
Company Information

Learn more about Amylin by clicking on the links below.

View and download our Corporate Brochure
View and download our 2008 Annual Report

News and Events
Amylin to Present at Piper Jaffray Europe Conference

Amylin to Present at Piper Jaffray Europe Conference
June 17, 2009 at 4:00 p.m. ET

  

Meta-Analysis of Clinical Data Showed No Increased Risk of...
June 8, 2009 at 4:00 p.m. ET

  

Exenatide Once Weekly Provided Sustained Improvements in Glycemic...
June 6, 2009 at 11:00 a.m. ET

More News » More Events »

Home | About Us | Pipeline | Research | Investors | Careers
  		Site Map | Terms of Use | Updates | PRIVACY
© 2006 Amylin Pharmaceuticals, Inc. - All Rights Reserved